Drug intelligence / Profile preview

hemin + MIL88

Development stage
Preclinical
Modality
Nanoparticles → Drug Delivery Systems, Small Molecules
Administration
Intratumoral
01

Overview

Hemin + MIL88 (also referred to as Hemin@MIL88) is a research-stage, catalase-mimicking nanomaterial composed of hemin, an iron-containing metalloporphyrin, loaded onto the metal-organic framework (MOF) MIL-88. It is designed to function as an artificial enzyme that catalyzes the decomposition of endogenous hydrogen peroxide ($H_2O_2$) into oxygen ($O_2$) within the tumor microenvironment. This process is intended to alleviate tumor hypoxia, a significant barrier to the efficacy of photodynamic therapy (PDT). In preclinical studies, Hemin@MIL88 has been integrated into injectable G-quadruplex hydrogel systems (such as HMI@GEL) alongside other therapeutic agents like metformin and indocyanine green (ICG) to provide a synergistic approach to breast cancer treatment through combined photothermal therapy, enhanced PDT, and mitochondrial respiration inhibition.

Other names
Hemin@MIL88hemin-loaded MIL-88

Beyond the preview

Go deeper on hemin + MIL88.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on hemin + MIL88.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call